XNAS · ALDX
+0.32% · +$0.0050 · Vol 789.8K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc.

PHARMACEUTICAL PREPARATIONS
$1.56
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
ALDX
Aldeyra Therapeutics, Inc.
Mon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

66/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ALDX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ALDX catalysts
About Aldeyra Therapeutics, Inc.
PHARMACEUTICAL PREPARATIONS
Listed since
2014
Employees
6
Country
US

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.55
Day high
$1.58
Day low
$1.52
Previous close
$1.56
52W high
$5.89
-73.43% from high
52W low
$1.24
7% of range
Market cap
$94.1M
EPS
$-0.4400
Beta
1.40
Shares out
60.3M
Volume
789.8K
0.68× rel vol
Avg volume
1.2M
VWAP
$1.55
Price history computed in-house
1W
+3.64%
1M
-7.40%
3M
+0.97%
1Y
-71.23%
YTD
-69.79%
SMA 50 $1.79 · below
SMA 200 $3.26 · below
52W position 7%

ALDX overview

Veridion Score
66
Daily close · 2026-08-17
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ALDX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ALDX Form 4 filings
Public disclosures

Congress activity in ALDX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ALDX in the cached public ledger.

Federal contracts

ALDX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ALDX in this window.
Lobbying spend

ALDX lobbying filings, year to date.

Registered lobbying filings matched to Aldeyra Therapeutics, Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ALDX in this window.
Loading news for ALDX
Analyst ratings
Sovereign unlock shows live analyst consensus for ALDX.
Options
Sovereign unlock shows live options positioning for ALDX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.